Tiina Noronkoski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tiina Noronkoski has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Ilkka Mononen
Department of Clinical Chemistry and Hematology, Turku University Central Hospital, P.O. Box 52, FIN-20521 Turku, Finland
2 shared publications Dimiter D Petkov
Laboratory of Biocatalysis, Institute of Organic Chemistry, Bulgarian Academy of Sciences, BG-1113 Sofia, Bulgaria
1 shared publicationDimiter D. Petkov
1 shared publication- Eira Kelo
Department of Clinical Chemistry, Kuopio University Hospital, Finland
1 shared publication Georgi I. Ivanov
1 shared publicationIvanka B Stoineva
Laboratory of Biocatalysis, Institute of Organic Chemistry, Bulgarian Academy of Sciences, BG-1113 Sofia, Bulgaria
1 shared publication
Latest Publications
- 28 August 2002
- Published by Wiley in FEBS Letters
- Vol. 528 (1-3) , 130-132
β‐Aspartylpeptides as substrates of L‐asparaginases from Escherichia coli and Erwinia chrysanthemi
L‐Asparaginase is known to catalyze the hydrolysis of L‐asparagine to L‐aspartic and ammonia, but little is known about its action on peptides. When we incubated L‐asparaginases purified either from Escherichia coli or Erwinia chrysanthemi – commonly used as chemotherapeutic agents because of their antitumour activity – with eight small β‐aspartylpeptides such as β‐aspartylserineamide, β‐aspartylalanineamide, β‐aspartylglycineamide and β‐aspartylglycine, we found that both L‐asparaginases could catalyze the hydrolysis of five of them yielding L‐aspartic acid and amino acids or peptides. Our data show that L‐asparaginases can hydrolyze β‐aspartylpeptides and suggest that L‐asparaginase therapy may affect the metabolism of β‐aspartylpeptides present in human body.
- 28 August 2002
- Published by Wiley in FEBS Letters
- Vol. 528 (1-3) , 130-132
β‐Aspartylpeptides as substrates of L‐asparaginases from Escherichia coli and Erwinia chrysanthemi
L‐Asparaginase is known to catalyze the hydrolysis of L‐asparagine to L‐aspartic and ammonia, but little is known about its action on peptides. When we incubated L‐asparaginases purified either from Escherichia coli or Erwinia chrysanthemi – commonly used as chemotherapeutic agents because of their antitumour activity – with eight small β‐aspartylpeptides such as β‐aspartylserineamide, β‐aspartylalanineamide, β‐aspartylglycineamide and β‐aspartylglycine, we found that both L‐asparaginases could catalyze the hydrolysis of five of them yielding L‐aspartic acid and amino acids or peptides. Our data show that L‐asparaginases can hydrolyze β‐aspartylpeptides and suggest that L‐asparaginase therapy may affect the metabolism of β‐aspartylpeptides present in human body.
- 17 January 1996
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 218 (2) , 510-513
Enzymatic Synthesis of the N-Glycosidic Bond by β-Aspartylation of Glycosylamines
- 17 January 1996
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 218 (2) , 510-513
Enzymatic Synthesis of the N-Glycosidic Bond by β-Aspartylation of Glycosylamines